Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-08

Clinical Trial Update: Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 2 study assessing how quickly RX-10045 works and how long its effects last in allergic conjunctivitis; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RX-10045

Snippet

Sponsor: C.T. Development America, Inc. | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED